Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: Psychiatric and socio-demographic correlates

This publication has 22 references indexed in Scilit:

• Relative Abuse Liability of GHB in Humans: A Comparison of Psychomotor, Subjective, and Cognitive Effects of Supratherapeutic Doses of Triazolam, Pentobarbital, and GHB
  Neuropsychopharmacology, 2006
• Lifetime Comorbidity of DSM-IV Mood and Anxiety Disorders and Specific Drug Use Disorders
  The Journal of Clinical Psychiatry, 2006
• Gender differences in response to lorazepam in a human drug discrimination study
  Journal of Psychopharmacology, 2005
• Reinforcing effects of diazepam under anxiogenic conditions in individuals with social anxiety.
  Experimental and Clinical Psychopharmacology, 2005
• Comparative Abuse Liability and Pharmacological Effects of Meprobamate, Triazolam, and Butabarbital
  Journal of Clinical Psychopharmacology, 2003
• Psychotropic Medication Expenditures for Community-Dwelling Elderly Persons
  Psychiatric Services, 2003
• Anxiolytics’ Effects on the Actual Driving Performance of Patients and Healthy Volunteers in a Standardized Test
  Neuropsychobiology, 1995
• Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States
  Archives of General Psychiatry, 1994
• Benzodiazepines of long and short elimination half-life and the risk of hip fracture
  JAMA, 1989
• Benzodiazepine withdrawal: Overview and implications for the treatment of anxiety
  The American Journal of Medicine, 1988